Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MSI Methylation Sciences Inc.

methylationsciences.com

Latest From MSI Methylation Sciences Inc.

Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q3 2011

Biopharma financing dropped in Q3 2011 to $1.3 billion, down from $6.3 billion in Q2. There were 20 M&A deals that totaled $30.9 billion, attributed mainly to the $27.7 million merger of PBMs Express Scripts and Medco. Almost a quarter of the alliances penned were for preclinical assets.

BioPharmaceutical Deals

On The Move

Recent Financings of Private Companies (11/2011)

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Nutraceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • MSI Methylation Sciences Inc.
  • Senior Management
  • David MacDonald, PhD, CTO
    Nancy Harrison, Pres.
    Steven Targum, MD, CMO
  • Contact Info
  • MSI Methylation Sciences Inc.
    Phone: (604) 435-5155
    108-4475 Wayburne Dr.
    Burnaby, V5G 4X4
    Canada
Advertisement
Advertisement
UsernamePublicRestriction

Register